- Enhancing profitability by accelerating new business - - Q2 dividend set at KRW 400 per share, payment date scheduled for September 17 - Huons Global recovered from a temporary slowdown in the previous quarter, posting a significant turnaround in earnings. Huons Global Co., Ltd. (co-CEOs Yoon Sung-tae and Song Soo-young), the holding compan..

- EPO exports drive growth…Expanding into the Middle East and South America in the second half of the year - - Turned a loss due to increased development costs for seven biosimilars -   PanGen Biotech(CEO Jaeseung Yoon), a subsidiary of Huons Group, reported revenue of KRW 3.96 billion and an operating loss of KRW 220 million for the second qua..

- Growth in new vaccine business and domestic pharmaceutical sales - - Q2 dividend set at KRW 200 per share, with the payment date scheduled for September 16 -     While Huons’ consolidated performance for the second quarter of this year slowed slightly, earnings rebounded on the back of strong sales in the pharmaceutical division and revenue grow..

- Establishes Foundation for Full-Scale Biopharmaceutical CMO Business - - To Manufacture Drug Product for Huonslab’s Hyaluronidase - Humedix is accelerating its expansion into the global biopharmaceutical contract manufacturing organization (CMO) market by strengthening its biopharmaceutical manufacturing capabilities. Humedix (CEO Kang Min-jong), ..

Huons Meditech Wins DermaShine Trademark Case in China -Court Orders Destruction of Counterfeit Products and Compensation- Huons Meditech, a medical device company under Huons Group, announced that it has secured a final victory in a trademark infringement lawsuit against a Chinese company that unlawfully used the trademarks of its flagship DermaShine series. ..

Huonslab Secures Patent for ADC Subcutaneous Formulation Incorporating ‘HyDIFFUZE™’ Platform -Demonstrates competitiveness of hyaluronidase-based ADC SC conversion platform- -Confirms stability of high-concentration ADC SC formulations and improved drug dispersion-   Huonslab, the R&D subsidiary of Huons Group, continues to strengthen it..